US dept buys Israeli burns treatment

The Biomedical Advanced Research & Development Authority (BARDA) – part of the US Department of Health – has awarded a $112 million contract to Israel’s Mediwound. BARDA will use Mediwound’s NexoBrid product in major incidents, to remove dead tissues from medium to severe burns. It will also help Mediwound finance its FDA approval for NexoBrid.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *